Page last updated: 2024-11-02

pd 98059 and Cirrhoses, Experimental Liver

pd 98059 has been researched along with Cirrhoses, Experimental Liver in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inagaki, Y1
Higashi, K1
Kushida, M1
Hong, YY1
Nakao, S1
Higashiyama, R1
Moro, T1
Itoh, J1
Mikami, T1
Kimura, T1
Shiota, G1
Kuwabara, I1
Okazaki, I1

Other Studies

1 other study available for pd 98059 and Cirrhoses, Experimental Liver

ArticleYear
Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7.
    Gastroenterology, 2008, Volume: 134, Issue:4

    Topics: Animals; Antibodies; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Culture

2008